The Smoking and Alcohol Toolkit Study: Home-based interviews and questionnaires to provide insights into current alcohol and tobacco use in people aged over 16 years in Scotland and Wales
| ISRCTN | ISRCTN75207361 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN75207361 |
| Secondary identifying numbers | CPMS 44840 |
- Submission date
- 17/02/2020
- Registration date
- 30/03/2020
- Last edited
- 19/03/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Plain English summary of protocol
Background and study aims
Smoking nicotine products and/or drinking alcohol can lead to diseases like diabetes, heart disease or stroke, amongst others, which otherwise could be avoided. Products like these are promoted heavily by international companies in a way that aims to increase the likelihood of people buying and consuming more of them than they should. By regularly collecting information over a long period of time about how often, how much and whether people are trying to stop (or have stopped) consuming these products, we can begin to understand how many people are at risk of being affected by avoidable diseases known as non-communicable diseases. By studying this information along with other details about individuals such as their age, employment status and where they live, we hope to be able to suggest better ways for policy makers to assist them to reduce or stop consuming these products and so avoid harm to their health.
Who can participate?
There is no open recruitment in the Smoking and Alcohol Toolkit Study. Participants in the research will be identified and contacted via IPSOS Mori. They will answer questions regarding their tobacco and alcohol use. No advice or recommendations will be provided to participants.
What does the study involve?
Each month Ipsos Mori will conduct 30-min home-based interviews using a tablet computer. Participants will be asked about their alcohol and tobacco use and about their attempts to reduce or stop their alcohol and tobacco consumption.
What are the possible benefits and risks of participating?
There are no personal or immediate benefits or risks related to participation.
Where is the study run from?
The Smoking and Alcohol Toolkit Studies are led by University College London (UK). The overall project is called SPECTRUM, whose headquarters are at the University of Edinburgh (UK).
When is the study starting and how long is it expected to run for?
June 2019 to March 2024
Who is funding the study?
UK Prevention Research Partnership (UKPRP)
Who is the main contact?
Linda Bauld, linda.bauld@ed.ac.uk
Contact information
Scientific
University College London
Gower Street
London
WC1E 6BT
United Kingdom
| Phone | +44 (0)207 679 5439 |
|---|---|
| jamie.brown@ucl.ac.uk |
Public
Usher Institute
Old Medical School
University of Edinburgh
Teviot Place
Edinburgh
EH8 9AG
United Kingdom
| Phone | +44 (0)131 650 3213 |
|---|---|
| linda.bauld@ed.ac.uk |
Study information
| Study design | Non-randomized; Observational; Design type: Cross-sectional |
|---|---|
| Primary study design | Observational |
| Secondary study design | Cross sectional study |
| Study setting(s) | Community |
| Study type | Other |
| Participant information sheet | No participant information sheet available |
| Scientific title | Shaping Public Health Policies to Reduce Inequalities and Harm: Developing and integrating new data sources to inform action |
| Study acronym | SPECTRUM |
| Study objectives | The SPECTRUM consortium aims to generate new evidence to inform the prevention of non-communicable diseases (NCDs) caused by unhealthy commodities in the UK and beyond. Through developing research in partnership with an extensive network of key organisations and the public, our vision is to transform policy and practice to encourage the adoption of healthy environments and behaviours. With a principal focus on tobacco and alcohol, two leading preventable causes of NCDs driven by unhealthy commodity producers, our work will extend as SPECTRUM develops to encompass other commercially driven diseases and harms. Our research will be coordinated through eight integrated Work Packages (WPs) focusing on: 1. Using systems to understand determinants and address harms 2. Addressing corporate conduct and influence 3. Developing and integrating new data sources to inform action 4. Conducting economic analysis to inform policy and practice 5. Shaping the environment to change behaviour and prevent harm 6. Evaluating the effectiveness of policies and natural experiments 7. Reducing inequalities including mental health 8. Building governance for health equity Each WP will involve empirical research underpinned by the systems approaches developed in WP1 and 2. SPECTRUM brings together a multi-disciplinary team of leading researchers from ten universities; the main NGO, professional and policy groups working on tobacco and alcohol in the UK, including many with a focus on inequalities and wider determinants of health; industry partners contributing new data and methods; and an independent advisory board of international experts. We will ensure that the public play a key role in our work through established engagement methods and new approaches such as citizens' juries. The proposed research programme will also inform prevention efforts internationally, through our extensive global networks including in low and middle-income countries, where commercially-driven NCDs are primary threats to future global health. The objective of this study is to expand detailed monthly surveillance of smoking and alcohol consumption from England across Great Britain. The establishment of the data source is exploratory. Individual studies that plan to make use of the data source will be pre-registered. |
| Ethics approval(s) | Approved 26/06/2019, University College London Ethics Committee (Office of the Vice-Provost (Research), University College London, 2 Taviton St, London, WC1E 6BT; +44 (0)20 7679 8717; ethics@ucl.ac.uk), ref: 2808/005 |
| Health condition(s) or problem(s) studied | Alcohol and tobacco use |
| Intervention | There is no open recruitment in the Smoking and Alcohol Toolkit Study. Participants in the research will be identified and contacted via IPSOS Mori. Each month Ipsos Mori will conduct 30-min home-based interviews using a tablet computer with 450-600 adults in Wales and 600-800 adults in Scotland, in addition to the ~1700 adults currently interviewed in England. Each monthly sample is designed to be representative of the population of England, Wales and Scotland aged 16+, using an established and verified methodology based on random selection of small areas of ~250 households. Sexes will be sampled equally to represent the population of Great Britain. Participants will answer questions regarding their tobacco and alcohol use. No advice or recommendations will be provided to participants. |
| Intervention type | Behavioural |
| Primary outcome measure | 1. Type of alcohol consumed and frequency of use 2. Type of nicotine product consumed and frequency of use |
| Secondary outcome measures | 1. Amount paid per week for cigarettes 2. Amount paid per week for tobacco 3. Amount paid per week for alcohol 4. Motivation to stop smoking 5. Motivation to stop drinking 6. Rate at which people are trying to stop unhealthy behaviours 7. Triggers for quit attempts 8. Receipt of advice to stop smoking or drinking from health professionals 9. Methods used in quit attempts 10. Success of quit attempts 11. Prevalence of attempts to reduce smoking or drinking 12. Use of aids to smoking reduction (particularly nicotine products) 13. Use of nicotine products in situations of enforced temporary abstinence |
| Overall study start date | 01/06/2019 |
| Completion date | 18/03/2024 |
Eligibility
| Participant type(s) | All |
|---|---|
| Age group | Adult |
| Lower age limit | 16 Years |
| Sex | Both |
| Target number of participants | Planned Sample Size: 50400; UK Sample Size: 50400 |
| Total final enrolment | 27925 |
| Key inclusion criteria | 1. Adults aged 16 years or over 2. Able to communicate in English 3. Resident in Scotland or Wales. |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 01/06/2020 |
| Date of final enrolment | 18/03/2024 |
Locations
Countries of recruitment
- Scotland
- United Kingdom
Study participating centre
University of Edinburgh
Teviot Place
Edinburgh
EH8 9AG
United Kingdom
Sponsor information
University/education
Usher Institute
Old Medical School
University of Edinburgh
Teviot Place
Edinburgh
EH8 9AG
Scotland
United Kingdom
| Phone | +44 (0)131 650 4332 |
|---|---|
| Sancha.martin@ed.ac.uk | |
| Website | http://www.ed.ac.uk/home |
"ROR" |
https://ror.org/01nrxwf90 |
Funders
Funder type
Other
No information available
Results and Publications
| Intention to publish date | 31/03/2024 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Available on request |
| Publication and dissemination plan | All research findings will be prepared for publication in high impact peer reviewed journals throughout the study and within one year of the funding end date. |
| IPD sharing plan | The investigators subscribe to the principles embodied in the Open Science Framework and commit to routinely providing data sets and analysis scripts for all published work (which will be provided on Open Science Framework: https://osf.io/) wherever feasible to do so. The investigators commit to sharing the complete dataset collected for Smoking and Alcohol Toolkit Studies in Scotland and Wales 1 year after the end of the consortium on Open Science Framework and UCL’s institutional repository for at least 10 years to those who complete a data access application form. During the life of the SPECTRUM consortium, the investigators will also make complete datasets including as yet unpublished data available on request on a case-by-case basis given the need to co-ordinate activities of different research groups. Following a request, to ensure that data will be used appropriately, they will ask for a data sharing agreement and conflicts of interest statement to be completed. Jamie Brown, with the support of the wider management group, will review requests for data sharing on a case-by-case basis in view of the overall aims of the ongoing research priorities within the current funding proposal, integrity of the request and viability of the proposed use of data as outlined in the data sharing agreement. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | 12/03/2024 | 19/03/2024 | Yes | No |
Editorial Notes
19/03/2024: The following changes have been made to the study record:
1. Publication reference and total final enrolment added.
2. The recruitment end date was changed from 30/03/2024 to 18/03/2024.
3. The overall study end date was changed from 30/09/2024 to 18/03/2024.
4. The intention to publish date was changed from 30/09/2025 to 31/03/2024.
19/03/2024: Publication reference added.
14/02/2020: Trial's existence confirmed by the National Institute for Health Research (NIHR).
